In This Article:
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card!
The CEO of Quick Heal Technologies Limited (NSE:QUICKHEAL) is Kailash Katkar. This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. Next, we'll consider growth that the business demonstrates. Third, we'll reflect on the total return to shareholders over three years, as a second measure of business performance. This method should give us information to assess how appropriately the company pays the CEO.
Check out our latest analysis for Quick Heal Technologies
How Does Kailash Katkar's Compensation Compare With Similar Sized Companies?
According to our data, Quick Heal Technologies Limited has a market capitalization of ₹14b, and pays its CEO total annual compensation worth ₹12m. (This is based on the year to March 2018). While this analysis focuses on total compensation, it's worth noting the salary is lower, valued at ₹11m. When we examined a selection of companies with market caps ranging from ₹6.9b to ₹28b, we found the median CEO total compensation was ₹16m.
That means Kailash Katkar receives fairly typical remuneration for the CEO of a company that size. While this data point isn't particularly informative alone, it gains more meaning when considered with business performance.
The graphic below shows how CEO compensation at Quick Heal Technologies has changed from year to year.
Is Quick Heal Technologies Limited Growing?
Over the last three years Quick Heal Technologies Limited has grown its earnings per share (EPS) by an average of 15% per year (using a line of best fit). Its revenue is down -1.1% over last year.
This demonstrates that the company has been improving recently. A good result. The lack of revenue growth isn't ideal, but it is the bottom line that counts most in business. We don't have analyst forecasts, but shareholders might want to examine this detailed historical graph of earnings, revenue and cash flow.
Has Quick Heal Technologies Limited Been A Good Investment?
Since shareholders would have lost about 13% over three years, some Quick Heal Technologies Limited shareholders would surely be feeling negative emotions. It therefore might be upsetting for shareholders if the CEO were paid generously.
In Summary...
Kailash Katkar is paid around the same as most CEOs of similar size companies.
We'd say the company can boast of its EPS growth, but we find the returns over the last three years to be lacking. Considering the improvement in earnings per share, one could argue that the CEO pay is appropriate, albeit not too low. Whatever your view on compensation, you might want to check if insiders are buying or selling Quick Heal Technologies shares (free trial).